UFPT trades 1.8% above Wall Street's consensus target of $298.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes UFPT achieves its forward estimates and maintains a stable P/E multiple of 31.1x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, UFP Technologies, Inc. (UFPT) has a Wall Street consensus price target of $298.00, based on estimates from 2 covering analysts. With the stock currently trading at $303.47, this represents a potential downside of -1.8%. The company has a market capitalization of $2.35B.
Analyst price targets range from a low of $252.00 to a high of $344.00, representing a 31% spread in expectations. The median target of $298.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, UFPT trades at a trailing P/E of 31.0x and forward P/E of 31.1x. The forward PEG ratio of 0.83 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +5.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $392.51, with bear and bull scenarios of $247.28 and $517.17 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 PFBCPreferred Bank | $1.2B | $102.89 | $120.00 | +16.6% | Buy | 9.5x | 10 |
 CPACCementos Pacasmayo S.A.A. | $1.1B | $12.73 | $12.96 | +1.8% | Hold | 4.0x | 8 |
 ITGRInteger Holdings Corporation | $4.3B | $126.56 | $118.25 | -6.6% | Buy | 20.8x | 16 |
 NNBRNN, Inc. | $145M | $2.75 | $7.00 | +154.5% | Buy | 14.5x | 9 |
 ESABESAB Corporation | $5.0B | $82.83 | $121.75 | +47.0% | Buy | 15.4x | 10 |
 LGNDLigand Pharmaceuticals Incorporated | $6.1B | $306.20 | $342.00 | +11.7% | Buy | 32.2x | 18 |
 SLGNSilgan Holdings Inc. | $4.3B | $41.09 | $49.67 | +20.9% | Buy | 10.6x | 21 |
 PACKRanpak Holdings Corp. | $311M | $3.63 | $9.38 | +158.4% | Buy | — | 5 |
 LYBLyondellBasell Industries N.V. | $19.6B | $60.72 | $69.56 | +14.6% | Hold | 6.7x | 40 |
 DOWDow Inc. | $22.7B | $31.40 | $34.60 | +10.2% | Hold | 12.1x | 36 |
Quick answers to the most common questions about buying UFPT stock.
Wall Street's consensus price target for UFPT is $298, -1.8% from its current price of $303.47. The below-market target from 2 analysts suggests limited near-term appreciation.
UFPT has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $298 implies -1.8% downside from current levels.
UFPT trades at a forward P/E of 31.1491x, representing a moderate valuation. With analysts targeting $298 (-1.8% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $344 for UFPT, while the most conservative target is $252. The consensus of $298 represents the median expectation. Our quantitative valuation model projects a bull case target of $517 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
UFPT is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UFPT stock forecast based on 2 Wall Street analysts shows a consensus price target of $298, with estimates ranging from $252 (bear case) to $344 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $393, with bear/bull scenarios of $247/$517.
Our quantitative valuation model calculates UFPT's fair value at $393 (base case), with a bear case of $247 and bull case of $517. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.
UFPT trades at a forward P/E ratio of 31.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 31.0x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on UFPT, with 0 Sell ratings and a price target of $298 (-1.8% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UFPT analyst price targets range from $252 to $344, a 31% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $298 consensus represents the middle ground. Our model's $247-$517 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.